ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1667

Impact of Rheumatoid Arthritis On Recognition of Hypertension in a Medically Homed Population

Christie M. Bartels1, Heather Johnson2, Katya Voelker3, Patrick Mc Bride4 and Maureen Smith5, 1Rheumatology/Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, 2Cardiology/Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, 3Univ of Wisconsin School of Medicine and Public Health, Madison, AA, 4Cardiology/Medicine, Univ of Wisconsin School of Medicine and Public Health, Madison, WI, 5Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: hypertension, quality of care and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Epidemiology and Health Services Research III: Rheumatic Diseases and Cardiovascular Disease and Risk Assessment

Session Type: Abstract Submissions (ACR)

Impact of Rheumatoid Arthritis on Recognition of Hypertension in a Medically Homed Population

Background/Purpose: Numerous studies report increased cardiovascular disease (CVD) events and others describe increased arterial stiffness in patients with rheumatoid arthritis (RA). Still, hypertension diagnosis rates in RA reports are often lower than expected by age.   We tested the hypothesis that RA is a risk factor for missed hypertension diagnosis, given the importance of hypertension for CVD risk.

Methods: Using a cohort design we studied all medically homed adult patients from a large multispecialty practice who met Joint National Committee-7 (JNC-7) hypertension diagnostic criteria but lacked baseline diagnosis or treatment to compare new recognition of hypertension in patients with and without RA. “Medically homed” definitions required ≥2 primary care visits over ≥12 months (2009-11), and RA/inflammatory arthritis algorithms required two ICD-9 claims of 714 in 24 months. Cox proportional hazard modeling was used to examine the impact of RA on hypertension recognition.

Results: Among 33,947 medically homed patients with baseline undiagnosed and untreated hypertension, 575 patients had RA codes. After an average of 14 months follow up, 49% of RA patients compared to 42% without RA remained undiagnosed. RA patients had equal annual primary care visits (mean 1.5 v. 1.6), more total provider visits (mean 7.5 v. 4.6) and longer mean observation time, yet were less often diagnosed. In multivariate modeling controlling for socio-demographic factors, comorbidity, and utilization factors, the presence of rheumatoid arthritis decreased the likelihood of hypertension diagnosis or treatment by 21% [Hazard Ratio 0.79, Confidence Interval 0.71-0.89].

        Hypertension recognition was lower in RA than other comorbidities (Table 1), and contrasted with increased hypertension recognition in patients with diabetes or kidney disease.  RA patients were older (mean 62 v. 57 years), more female, weighed less, and were more likely to see an internist for primary care, and in the final adjusted model, younger age, white race, Medicaid, and non-internal medicine primary care provider predicted lower hypertension recognition.

Table 1. Cox Proportional Hazards Model for Hypertension Recognition

Unadjusted

Adjusted

 

% Diagnosed

HR

95% CI

Rheumatoid Arthritis

51

0.79

0.71-0.89

Depression

51

0.88

0.83-0.93

Hyperlipidemia

68.7

1.33

1.29-1.37

Diabetes

71.4

1.22

1.18-1.27

Chronic Kidney Disease

64.1

1.13

1.06-1.20

Ischemic Heart Disease

66.8

1.00

0.95-1.06

Peripheral Vascular Disease

67.1

1.09

1.03-1.16

Congestive Heart Failure

65.1

0.9

0.84-0.96

TIA/Stroke

55.3

0.9

0.84-0.96

Model also includes age, gender, weight, language, Medicaid, and utilization

Conclusion: In this sample of medically homed patients meeting JNC-7 criteria for hypertension those with RA were 21% less likely to be diagnosed or treated despite more total visits,  compared to those without RA. Given that both hypertension and RA increase cardiovascular risk, rheumatologists may need to actively help to improve hypertension recognition to modify CVD risk.

 


Disclosure:

C. M. Bartels,
None;

H. Johnson,
None;

K. Voelker,
None;

P. Mc Bride,
None;

M. Smith,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/impact-of-rheumatoid-arthritis-on-recognition-of-hypertension-in-a-medically-homed-population/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology